Case Report

Herpes Zoster Ophthalmicus and Encephalitis Following Botulinum Toxin Type A Injection for Blepharospasm: A Case Report


A 68- year – old male was admitted to ER of Referral Imam Khomeini hospital with abrupt commence of fever accompanied with debilitating non-radiating headache, photophobia, ataxia and cluster of confluent vesicles on right side of forehead with swelling of right eyelid. All his symptoms started after receiving Botulinum injection on the same week before admission and he had never had similar manifestations beforehand.His medical history was remarkable for hyperlipidemia, hypertension and right side Blepharospasm for which he received Botulinum injection every 6 months. He was on medication for the rest of his medical problems. He was not on any immunosuppressive medication and did not suffer from any disease weakening the immune system. His family history was unremarkable for any similar problems.In medical exam, he was ill but not toxic, his vital signs were blood pressure of 135/80 mmHg, heart rate of 76, respiratory rate of 17 and oral temperature of 38.5Ĉ. He had vesicles on his right forehead. Heart sounds were regular without murmur. Lungs were clear. Abdominal examinations were inconspicuous.In neurological examinations, he was confused and disoriented to time and place. Cranial nerves were without any pathological findings except for positive Marcus Gunn of affected side and blurring of right optic disk margin. No muscle atrophy was seen. Muscle force showed no weakness. He was ataxic. Sensory examination was normal. Reflexes were checked and were within normal limits and symmetric.Computer tomography (CT) scan of head was unremarkable and his MRI scan did not reveal any information compatible with his symptoms.Due to the sudden onset of fever with headache and confusion, encephalitis was suspected and empirical therapy with antibiotics was started and LP was performed which indicated pleocytosis in CSF. According to the vesicles on the skin and with suspicion of Varicella encephalitis, PCR was sent for diagnosis of VZV. Subsequently, his condition got dramatically better and symptoms diminished after acyclovir was started.

[1] Yawn BP, Gilden D. Global perspectives. Neurology. 2013;81(10):928-930. 3182a3516e [PMID:23999562]
[2] Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of her- pes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5). ml/rr57e0515a1.htm
[3] Kennedy PGE, Gershon AA. Clinical features of varicella-zoster virus infection. Viruses. 2018;10(11). v10110609 [PMID:30400213]
[4] Tabaja H, Sharara SL, Abi Aad Y, et al. Varicella zoster virus infection of the central nervous system in a tertiary care center in Lebanon. Med Mal Infect. 2020;50(3):280-287. [PMID:31526545]
[5] Herlin LK, Hansen KS, Bodilsen J, et al. Varicella Zoster Virus En- cephalitis in Denmark From 2015 to 2019-A Nationwide Prospec- tive Cohort Study. Clin Infect Dis. Published online 2020:1-25. [PMID:32103249]
[6] Hackett CB, Wall D, Fitzgerald SF, Rogers S, Kirby B. Varicella-zos- ter virus immunity in dermatological patients on systemic im- munosuppressant treatment. Br J Dermatol. 2011;164(6):1387- 1389. [PMID:21410679]
[7] Saylor D, Thakur K, Venkatesan A. Acute encephali- tis in the immunocompromised individual. Curr Opin In- fect Dis. 2015; 28(4):330-336. QCO.0000000000000175 [PMID:26098507]
[8] Wiegering V, Schick J, Beer M, et al. Varicella-zoster virus infec- tions in immunocompromised patients - a single centre 6-years analysis. BMC Pediatr. 2011;11. 2431-11-31 [PMID:21569228]
[9] Lewis DJ, Schlichte MJ, Dao H. Atypical disseminated herpes zos- ter: Management guidelines in immunocompromised patients. Cutis. 2017;100(5):324-330. [PMID: 29232422]
[10] Imani S, Palavra NC, Oboudiyat C, Ip J. Varicella-zoster meningitis in an immunocompetent young man presenting with a painless erythematous rash. BMJ Case Rep. 2020;13(1). [PMID:31969416]
[11] Ramirez-Castaneda J, Jankovic J. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins (Basel). 2013;5(2):249-266.
[12] Dutton JJ, Buckley EG. Long-term Results and Complications of Botulinum A Toxin in the Treatment of Blepharospasm. Ophthalmology. 1988;95(11):1529-1534. https://doi. org/10.1016/S0161-6420(88)32977-5
[13] Ziaei M, Aslam SA, Ziaei H. Herpes zoster reactivation. Br Dent J. 2011;210(6):247-248.
[14] Bas B, Ózden B, Ózdemir M, Yüksel EP. Herpes zoster ophthalmicus reactivation following maxillary sinus lift operation: a case report. Eur J Oral Implantol. 2015;8(2):177-180.
[15] Clayton TH, Stables GI. Reactivation of ophthalmic herpes zoster following pulsed-dye laser treatment for inflammatory acne vulgaris. Br J Dermatol. 2005;152(3):569-570. https://doi. org/10.1111/j.1365-2133.2005.06395.x
[16] Jarade EF, Tabbara KF. Presumed reactivation of herpes zoster ophthalmicus following laser in situ keratomileusis. J Refract Surg. 2002;18(1):79-80. 597X-20020101-12
[17] Guttiganur N, Devanoorkar A, Aspalli S, Shetty S. Herpes zoster of trigeminal nerve after dental extraction. Indian J Dent Res. 2013;24(3):396.
[18] Graber EM, Dover JS, Arndt KA. Two cases of herpes zoster appearing after botulinum toxin type A injections. J Clin Aesthet Dermatol. 2011;4(10):49-51.
[19] Gadient PM, Smith JH, Ryan SJ. Herpes zoster ophthal- micus following onabotulinumtoxinA administration for chronic migraine: A case report and literature re- view. Cephalalgia. 2015;35(5):443-448. https://doi. org/10.1177/0333102414544974
IssueVol 7 No 2 (2022): March-April QRcode
SectionCase Report(s)
Herpes Zoster Ophthalmicus Encephalitis Botulinum Blepharospasm

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Farahmand G, Magrouni H, Zolfaghari V, Gharehjeh S, ranji -Burachaloo sakine. Herpes Zoster Ophthalmicus and Encephalitis Following Botulinum Toxin Type A Injection for Blepharospasm: A Case Report. CRCP. 2022;7(2):58-60.